ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 1 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $120,203,000 | +47.1% | 6,373,511 | -8.2% | 0.01% | +66.7% |
| Q2 2019 | $81,730,000 | +3.7% | 6,943,864 | +20.3% | 0.00% | -25.0% |
| Q1 2019 | $78,821,000 | +55.8% | 5,774,520 | +17.0% | 0.00% | +33.3% |
| Q4 2018 | $50,579,000 | -37.7% | 4,934,624 | +1.3% | 0.00% | -25.0% |
| Q3 2018 | $81,132,000 | +6.6% | 4,872,772 | +1.1% | 0.00% | 0.0% |
| Q2 2018 | $76,124,000 | +13.6% | 4,817,978 | -8.7% | 0.00% | +33.3% |
| Q1 2018 | $67,024,000 | +17.6% | 5,277,373 | +6.0% | 0.00% | 0.0% |
| Q4 2017 | $56,984,000 | -7.2% | 4,976,663 | -0.7% | 0.00% | 0.0% |
| Q3 2017 | $61,378,000 | +39.7% | 5,010,455 | +30.6% | 0.00% | +50.0% |
| Q2 2017 | $43,935,000 | -46.6% | 3,837,036 | -3.0% | 0.00% | -60.0% |
| Q1 2017 | $82,285,000 | +21272.7% | 3,956,052 | +21271.4% | 0.01% | +400.0% |
| Q4 2016 | $385,000 | -18.8% | 18,511 | +28.0% | 0.00% | 0.0% |
| Q3 2016 | $474,000 | +31.3% | 14,466 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $361,000 | -16.2% | 14,466 | -17.7% | 0.00% | 0.0% |
| Q1 2016 | $431,000 | -82.0% | 17,586 | -75.7% | 0.00% | -75.0% |
| Q4 2015 | $2,395,000 | -12.8% | 72,511 | -13.5% | 0.00% | 0.0% |
| Q3 2015 | $2,747,000 | -54.1% | 83,855 | -25.8% | 0.00% | -55.6% |
| Q2 2015 | $5,983,000 | +76.9% | 112,955 | -3.6% | 0.01% | +80.0% |
| Q1 2015 | $3,383,000 | +80.0% | 117,202 | +81.4% | 0.01% | +66.7% |
| Q4 2014 | $1,879,000 | +130.0% | 64,602 | +0.3% | 0.00% | +200.0% |
| Q3 2014 | $817,000 | -40.9% | 64,400 | -6.5% | 0.00% | -50.0% |
| Q2 2014 | $1,383,000 | – | 68,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |